Health Technology Assessment

We seek pharmaceutical assessment which incorporates patient-driven evidence and perspectives and leads to improved patient care.

BMC Position Points: Patient input to Canada’s Drug Agency to support and inform reimbursement deliberations and related Issues (June 11, 2025)

Health Technology Assessment in Canada: Improving the System and Ensuring the Patient Voice is Heard (February 2014)

Go to the top
BMC position points: Protecting patients in Canada from tariff and other trade measures
This is default text for notification bar
Learn more